The new Colorectal Center at USC/Norris
Comprehensive Cancer Center entwines
the full spectrum of colorectal cancer health professionals and
resources into one vital lifeline for parents. by Alicia Di Rado
At USC/Norris, colorectal cancer patients anxious
about treatment can be matched up with an advocate who has gone
through it all before. They can rely on frank talk with a physical
therapist who helps them recover from surgery. And a monthly support
group meeting unites them with others facing the same challenges.
Yet these services provide only a window into
the caring team that colon and rectal cancer patients can expect
at USC/Norris. Successfully combating cancer and coping with its
many lasting effects requires a call to arms that only a full
squad of talented professionals from a variety of disciplines
can answer.
That is why professionals dedicated to colorectal
cancer—patient advocates, oncologists, nurses, surgeons,
social workers, nutritionists and counselors, among many others—all
have a single place to call home at USC/Norris. That place is
the new Colorectal Center, an endeavor that entwines all of the
Norris’ colorectal cancer resources into one vital lifeline
for patients.
“We want this to be the colon cancer
center nationwide,” says Heinz-Josef Lenz, M.D., associate
professor of medicine and director of USC/Norris’ gastrointestinal
oncology program. “This will set the gold standard for treatment.”
Robert W. Beart Jr., M.D., the Charles and
Carolyn Costello Professor of Surgery, likens the approach to
that of the Harold E. and Henrietta C. Lee Breast Center at USC/Norris,
where everyone important to patient care unites under one banner.
“It’s not that we haven’t
had all the elements for this center before, but they haven’t
been coordinated in a timely fashion for patients,” explains
Beart, who also holds the Audrey Skirball-Kenis Chair for Colorectal
Diseases.
And, of course, they aim to bring the once-taboo
topic of colon and rectal cancer to the forefront. Their most
valuable tool: a cadre of dedicated health professionals.
One place Physicians’ knowledge and judgment,
combined with that of fellow professionals, provide a framework
for decisions that patients and their caregivers must make during
treatment and beyond.
When patients are diagnosed with colon or rectal
cancer, their treatment depends on the cancer’s credentials:
How big is it? Where is it? Has it spread through the wall of
the colon or rectum, and has it metastasized to nearby or far-away
organs? Is it slow-growing or aggressive?
Such cancers are most often diagnosed during
a colonoscopy, when a surgeon may snip a suspicious polyp and
send it to the USC/Norris pathology lab for examination. The pathologist,
a physician specially trained to recognize and characterize cancer
cells, examines the thinly sliced and dyed tissue sample under
a microscope to see if cells are abnormal.
Other physicians known as radiologists also
hunt down cancer clues through images of the colon and other parts
of the body using barium enemas, ultrasound, computed tomography
studies, magnetic resonance imaging and other techniques.
Surgeons such as Beart then remove tumors, check for cancer spread,
and reconstruct the bowel so patients retain the highest-possible
function.
For many patients, chemotherapy is the next
step. Medical oncologists such as Lenz and Syma Iqbal, M.D., assistant
professor of medicine, create a sort of genetic fingerprint of
the patient’s particular cancer before customizing a plan
for administering chemotherapy drugs.
They run a barrage of tests to find genetic
markers that can steer them to a menu of anti-cancer drugs with
the greatest potential to fight the tumor.
Sometimes they provide chemotherapy before
surgery to shrink tumors, making them easier to take out while
preserving important tissue. And in the case of rectal cancer,
a physician such as Emily L. Militzer, M.D., assistant professor
of radiation oncology, may join the team to administer radiation
therapy. These high-energy rays can shrink tumors before surgery
or kill any tiny deposits of cancerous cells that might remain
behind after surgery.
Other treatments are possible too, depending
on the cancer’s stage.
If cancer has metastasized to the liver, Rick
Selby, M.D., professor of surgery and chief of the division of
hepatobiliary and pancreatic surgery, joins the team to remove
liver tumors in a follow-up operation. Tumors in the liver can
show up as late as five years after the initial colon cancer treatment.
“Probably 5 to 25 percent of patients
have these tumors,” Selby says. “We recommend liver
resection whenever we can render the patient disease free. We
can take out up to 75 percent of the liver.”
With so many physicians, therapists and nurses
with differing schedules potentially involved in the treatment
of one patient, speedy communication can be complicated. Bringing
Colorectal Center team members together in the same place on a
regular schedule streamlines that communication—and benefits
patients.
“This system is a lot more efficient
in terms of decision-making,” Selby says. “There’s
a brainstorming effort. We can all sit down and ask questions:
Should a patient have chemotherapy before or after surgery? Should
they be in a clinical trial?
“This way, we can come to a conclusion
by consensus, which ultimately helps the patient.”
Lenz says it offers patients convenience, a
key point particularly for those who travel long distances. The
USC/Norris colorectal cancer program is so widely recognized that
patients come not only from all over the U.S. but from Asia, South
America and Europe for treatment. USC physicians see more colorectal
cancer patients than any other treatment center in California.
“When patients come from far away, they
want a comprehensive workup in one place, at one time,”
Lenz says. “They can schedule tests and appointments with
different people for the same day, and don’t have to keep
coming back.”
Key players
Nurses form the front line of the Colorectal Center. When patients
get a fever, they call a nurse. When they are having trouble with
a colostomy after surgery, they call a nurse.
And when they are frustrated or scared, they call a nurse.
Yolee Casagrande, R.N., is clinical nurse coordinator
at the center. She can flip through her memory like a Rolodex,
remembering seemingly every patient.
Casagrande matches worried patients with other
survivors for support. “Let’s say there’s a
53-year-old man who is going to undergo surgery,” she says.
“I try to match him with someone he can relate to, someone
who has been there before and can tell him first-hand what to
expect.
“Sometimes patients tell each other things
and feel a bond that they feel with no one else.”
This sensitivity makes its way to patient care,
and it matters. “Psychosocial issues are very important
to our patients,” Beart says. “It’s not a matter
of getting through surgery or chemotherapy and that’s it,
they’re done. These patients have to deal with having a
chronic disease.
“Nurses are involved with patients even
before surgery. Nurses become the floor on which this whole center
stands.”
Casagrande is overseeing the creation of educational
materials for all patients. The center will have an office dedicated
to patient education, as well as a Web site.
“Every patient will receive an individualized
manual that will address issues specific to them,” Casagrande
explains. “For example, it would not make sense to include
information about radiation therapy for a patient getting treatment
for colon cancer, since radiation is used for rectal cancer patients.
“We want to include information that
is customized exclusively for each patient.”
Lenz is enthusiastic about the materials’
modular format. Educators may insert modules in each patient’s
manual as needed, and everyone will get a sheet with answers to
frequently asked questions and a listing of emergency phone numbers.
“It’s been shown that patients
miss 85 percent of what they are told during doctors’ visits,”
Beart says, “so this will be a great reference.”
Team togetherness
“Each person in this program has an active role in helping
the patient, right from the get-go,” says Beart. Each performs
invaluable services that better the Colorectal Center, he notes,
listing the team members: social workers, stoma therapists, nutritionists,
radiation therapists, genetic counselors, physical therapists
and their assistants.
Social workers, for one, help with depression
and quality-of-life issues. Even after treatment, many patients
have lasting problems with parts of life that might ordinarily
be taken for granted, such as sexual relationships. Social workers
listen and suggest ways to cope.
They also offer a support group for colorectal
cancer patients once a month, Casagrande notes. Patients’
caregivers and family members are welcome, too. And a special
luncheon each March reunites patients with friends made during
treatment.
In addition, a new patient liaison and coordinator
serves as an advocate for patients. A former colon cancer patient,
the coordinator answers patients’ questions, shepherds patients
from physician to physician and wards off possible paperwork tangles.
A nutritionist guides patients on dietary recommendations,
following proven research findings on foods and nutrients needed
for overall health. Physical therapist Julie Reynolds, Ph.D.,
also helps. She provides therapy to battle incontinence, especially
among rectal cancer patients, who are instructed on focused exercises
to strengthen sphincter muscles.
And when patients might have an inherited,
genetic basis for their cancer, genetic counselor Monica Alvarado,
M.S., C.G.C., can work with patients’ family members to
assess their cancer risk.
“We envision family screenings and chemoprevention
protocols,” says Lenz. When family members are seen to be
at high risk for colon cancer, they may be put on a more aggressive
screening schedule to detect cancer early.
Lenz notes that identifying families with an
inherited cancer risk also fits into the work of USC/Norris researcher
Robert Haile, Dr.P.H., who directs a growing national registry
of families at high risk for developing colorectal cancer (see
“All in the Family,” page 8). The idea: to find new
candidate genes linked to colorectal cancer risk.
Haile is not only looking at the genetic causes
of cancer, but also environmental ones—as well as how to
stop cancer from happening in the first place. For example, in
a recent study, he and his colleagues found that taking aspirin
can reduce the risk of colon cancer in those at high risk for
the disease. Calcium, folic acid and substances in broccoli, cabbage
and other cruciferous vegetables are just a few of the other compounds
under study.
In the future, patients and families may be
able to access trials involving such substances, Lenz says. Patients
may also benefit from USC/Norris research on new treatments.
“The better we work together clinically,
the better we can get research advances to patients,” he
adds.
Beart, meanwhile, is focused on providing the
best possible day-to-day management of patients, using advanced
therapies. His ultimate measure of the center team’s success
lies in the patients themselves.
“Nationally, there’s a tremendous
body of data that says that colon cancer treatment by physicians
specializing in the disease means better outcomes than does treatment
from general surgeons. But we aren’t resting on that laurel,”
Beart says. “We don’t just want to address patients’
cure rates, but their overall well-being—and that of their
family members.”
For more information about the Colorectal Center
or The Doctors of USC, call 1-800-USC-CARE (1-800-872-2273).